S&P 500
7,226.20
+0.01%
Dow Jones
49,494.60
-0.62%
Nasdaq 100
27,685.40
+0.66%
Russell 2000
2,804.78
-0.02%
FTSE 100
10,364.50
0.00%
Nikkei 225
59,260.50
-0.78%

Investing

Pre-Market Stock News (October 15, 2007)

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published
Follow 24/7 Wall St. on Google
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

(APC) Anadarko filed for a spin-off of its Western Gas Partners LP.
(BIIB) Biogen-Idec trading up 18% after announcing it was putting itself up for sale.
(C) Citigroup $0.47 EPS vs. $0.44 est.; stock up 1% pre-market.
(CMED) China Medical Tech received Korean FDA approval for its HIFU system.
(CRA) Celera Genomics and collaboration team identified a risk score to predict genetic coronary disease.
(ELN) Elan hired Lehman for advice on Tysabri review extension from FDA; stock up over 10%.
(ETN) Eaton $1.67 EPS vs $1.68 est.
(GENZ) Genzyme presented positive results from Phase II of Alemtuzumab in Multiple Sclerosis studies.
(GLGC) Gene Logic agrees to sell its Genomics assets.
(MAT) Mattel $0.61 EPS vs $0.70 est, although that number includes some charges; stock down almost 1%.
(MDT) Medtronic suspended distribution of Sprint Fidelis(R) defibrillation leads on voluntary basis.
(NWS) News Corp.’s Fox Business News launches today.
(PCOP) Pharmacopeia acquired a selective androgen receptor modulator program from Bristol-Myers Squibb.
(PRM) Primedia put full year revenue guidance flat to low single digits versus previous "low single digit" guidance.
(TEK) Textronix gets $38 buyout from Danaher (DHR) in a $2.8 Billion deal.
(TELK) Telik said the FDA removed a partial hold on TELCYTA clinical development; stock up nearly 20%.
(VSAT) ViaSat was awared an $8.7 million contract to modernize Air Force telemetry tracking and control cryptographic units.
(WNG) Washington Group raised guidance.

Jon C. Ogg
October 15, 2007

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Continue Reading

Douglas A. McIntyre |

Top Day Trader Alerts (AONE, SAP, ORCL, ROSG, SEED, EK)

These are this Thursday’s top early bird day trader and active trader alert stocks moving on unusual volume.  We have…
Jon C. Ogg |

How Dendreon’s Good News Could Spread Around Biotech (DNDN, HGSI, IBB, FBT)

Dendreon Corporation (NASDAQ: DNDN) is living up to something we showed late in December.  It was one of the Top…
Douglas A. McIntyre |

J C Penney Slashes Guidance (JCP, DDS, M)

J. C. Penney Company, Inc. (NYSE:JCP) has just revised its sales and earnings guidance for the first quarter.  Of course…
Chris Lange |

Fluidigm Tumbles on Weak Earnings

Shares tumbled after Fluidigm reported disappointing second-quarter financial results and lowered guidance.
RBC Says These 4 Top Biotechs Could Have Big Upside Potential
Lee Jackson |

RBC Says These 4 Top Biotechs Could Have Big Upside Potential

An RBC report noted that although headline issues such as the Federal Reserve and the election are increasing volatility, four…
5 Buy-Rated Stocks Trading Under $10 With Huge 2022 New Year’s Potential
Lee Jackson |

5 Buy-Rated Stocks Trading Under $10 With Huge 2022 New Year’s Potential

These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential.…
Good News and Bad From Target
Paul Ausick |

Good News and Bad From Target

Mega-retailer Target said Thursday that online sales are booming, while store sales have been hurt by lockdowns related to COVID-19.…
Gap Is Still Falling Apart
Douglas A. McIntyre |

Gap Is Still Falling Apart

The market rewarded news that Gap will not spin out its Old Navy brand. The decision could not hide the…
5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher
Lee Jackson |

5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher

24/7 Wall St. screened the Merrill Lynch health care research database looking for large pharmaceutical leaders that also pay solid…

Top Gaining Stocks

Cboe Global Markets
CBOE • Vol: 1,568,143
New Pluto Global
PSKY • Vol: 12,285,993
Seagate Technology
STX • Vol: 7,378,346
Oracle
ORCL • Vol: 26,317,675
Datadog
DDOG • Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ • Vol: 4,367,433
Clorox
CLX • Vol: 13,260,523
Stryker
SYK • Vol: 4,519,455
Mohawk Industries
MHK • Vol: 1,859,865
Amgen
AMGN • Vol: 3,818,618